PMVP
Pmv Pharmaceuticals Inc
NASDAQ: PMVP · HEALTHCARE · BIOTECHNOLOGY
$1.39
-2.11% today
Updated 2026-04-29
Market cap
$74.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
Pmv Pharmaceuticals Inc (PMVP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-15.18M | $-22.07M | $-32.74M | $-46.57M | $-63.76M | $-55.66M | $-51.28M | $-73.58M |
| Capital expenditures | $452000.00 | $109000.00 | $148000.00 | $1.35M | $7.98M | $962000.00 | $655000.00 | $29000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.08M | $908000.00 | $1.93M | $5.34M | $10.20M | $12.38M | $8.87M | $5.92M |
| Free cash flow | $-15.63M | $-22.17M | $-32.89M | $-47.92M | $-71.74M | $-56.62M | $-51.94M | $-73.61M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $288.14M | $-188.13M | $-64.17M | — | — | — |